Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenax Therapeutics (TENX) Shares Outstanding (Weighted Average) (2016 - 2026)

Tenax Therapeutics' Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $1.4 million for Q4 2017.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.33% to $1.4 million in Q4 2017 year-over-year; TTM through Dec 2017 was $1.4 million, a 0.33% change, with the full-year FY2017 number at $1.4 million, down 94.98% from a year prior.
  • Shares Outstanding (Weighted Average) hit $1.4 million in Q4 2017 for Tenax Therapeutics, roughly flat from $1.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for TENX hit a ceiling of $28.1 million in Q3 2016 and a floor of $1.4 million in Q4 2016.
  • Historically, Shares Outstanding (Weighted Average) has averaged $14.9 million across 5 years, with a median of $9.4 million in 2014.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 1215.48% in 2014 and later tumbled 95.0% in 2016.
  • Tracing TENX's Shares Outstanding (Weighted Average) over 5 years: stood at $4.9 million in 2013, then skyrocketed by 467.28% to $28.0 million in 2014, then increased by 0.29% to $28.1 million in 2015, then tumbled by 95.0% to $1.4 million in 2016, then increased by 0.33% to $1.4 million in 2017.
  • Business Quant data shows Shares Outstanding (Weighted Average) for TENX at $1.4 million in Q4 2017, $1.4 million in Q3 2017, and $1.4 million in Q2 2017.